Log in

Relevant bibliographies by topics / Alopecia areata / Journal articles

To see the other types of publications on this topic, follow the link: Alopecia areata.

Journal articles on the topic 'Alopecia areata'

Author: Grafiati

Published: 4 June 2021

Last updated: 28 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Alopecia areata.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Kramov, N. "Treatment of alopeciae areatae. Bengtson (T. Amer, M. A. v. 97. No. 19)." Kazan medical journal 32, no. 8-9 (October 4, 2021): 788. http://dx.doi.org/10.17816/kazmj81578.

Full text

Abstract:

Treatment of alopeciae areatae. Bengtson (T. Amer, MA v. 97. No. 19), using pituitaris extract in 16 patients with alopecia areata, obtained excellent results: first lanugo appeared, and then hair, eyebrows, eyelashes, beard of the same color appeared, while the general condition improved. The patients were young and old.

APA, Harvard, Vancouver, ISO, and other styles

2

Toena, Haken Tennizar, and Retno Danarti. "Diagnosis Alopesia Areata Pada Anak: Kasus Serial." Cermin Dunia Kedokteran 49, no. 4 (April 1, 2022): 214. http://dx.doi.org/10.55175/cdk.v49i4.1824.

Full text

Abstract:

<p>Alopesia areata (AA) merupakan penyakit autoimun yang ditandai dengan alopesia non-sikatrisial. Kondisi ini merupakan dermatosis yang umum ditemui pada anak. Gambaran klinisnya berupa alopesia non-sikatrisial fokal, perlu dibedakan dari kondisi dapatan serupa lainnya, terutama yang sering terjadi pada anak. Kami melaporkan 5 kasus AA pada anak berusia di bawah 18 tahun. Diagnosis berdasarkan pemeriksaan klinis dan penunjang. Pemahaman karakteristik AA perlu diketahui untuk diagnosis, terutama pada pasien anak.</p><p>Alopecia areata (AA) is a chronic autoimmune disease characterized by non-scarring alopecia. It is one of the most commonly found dermatosis in pediatric population. The clinical manifestations of focal non-scarring alopecia must be differentiated from other acquired focal non-scarring alopecia, especially those in children. This paper report 5 AA cases in children. Diagnosis was based on clinical and supporting examinations. Understanding the characteristics of AA, particularly in children, is important to make correct diagnosis.</p>

APA, Harvard, Vancouver, ISO, and other styles

3

Tzur Bitan, Dana, Daniella Berzin, Khalaf Kridin, Yaron Sela, and Arnon Cohen. "Alopecia Areata as a Proximal Risk Factor for the Development of Comorbid Depression: A Population-based Study." Acta Dermato-Venereologica 102 (March 14, 2022): adv00669. http://dx.doi.org/10.2340/actadv.v102.1622.

Full text

Abstract:

Alopecia areata and depression tend to co-occur; however, their temporal association has not been comprehensively investigated. The aim of this study was to examine the temporal association between alopecia areata and depression. The study included only cases with a comorbid presentation of alopecia areata and depression (n = 1,936), extracted from the databases of the Clalit Health Services, Israel. Survival analyses were used to assess the cumulative probability of receiving alopecia areata as comorbid diagnosis in the years following depression, and vice versa, compared with the opposite trajectory. The results indicate that patients with alopecia areata had greater odds of subsequent depression within 2 years from alopecia areata diagnosis, and showed a steeper increase in cumulative probability of depression as time progressed (log-rank =336.38, p < 0.001), compared with the opposite trajectory. All patients with alopecia areata had comorbid depression within 10 years of alopecia areata, compared with 70% of depression patients receiving diagnoses of comorbid alopecia areata within the same time-frame.

APA, Harvard, Vancouver, ISO, and other styles

4

Yong, Angeline Anning, and Robin Unger. "Resistance of Transplanted Hair Follicles to the Onslaught of Diffuse Alopecia Areata." American Journal of Cosmetic Surgery 34, no. 2 (March 23, 2017): 70–72. http://dx.doi.org/10.1177/0748806817699926.

Full text

Abstract:

A 55-year-old man who previously underwent a successful hair transplantation for androgenetic alopecia now presents with rapid onset hair loss over the anterior to mid-scalp areas during a 2-month period. The alopecic area noticeably extended diffusely from anterior hairline to scalp vertex while rows of previously transplanted hair follicles appeared intact. Further dermoscopic features and a scalp biopsy were consistent with alopecia areata incognita. This patient was subsequently successfully treated with intralesional steroid injections. This case report is the first demonstrating the relative resistance of transplanted hair follicles to the process of alopecia areata when compared with local indigenous hairs. Prior to this, a few reports have demonstrated the use of hair transplantation to treat stable areas of alopecia areata resistant to medical treatment with mixed results but at least some initial success. This could be related to the local irritation and inflammatory response resultant from needling during hair transplantation that causes a degree of scarring and fibrosis around each transplanted graft, hence lending a protective barrier to an autoimmune-based T-lymphocyte attack on hair bulbs and subsequent increased survival of transplanted hair follicles. This unexpected observation provides new avenues for investigation into alopecia areata pathophysiology and further supports hair transplantation as a viable option for patients with stable, localized alopecia areata that is recalcitrant to other modalities.

APA, Harvard, Vancouver, ISO, and other styles

5

Kirshen, Carly, and Nordau Kanigsberg. "Alopecia Areata following Adalimumab." Journal of Cutaneous Medicine and Surgery 13, no. 1 (January 2009): 48–50. http://dx.doi.org/10.2310/7750.2008.07095.

Full text

Abstract:

Background: Alopecia areata is a nonscarring hair loss characterized by well-circumscribed patchy areas, most often on the scalp. The inflammatory cytokine tumor necrosis factor alpha (TNF-α), has been connected with the development of alopecia areata in vivo; thus, the TNF-α inhibitors have been cited as possible treatments for this autoimmune condition. Objective: We report a case of alopecia areata that developed in a 52-year-old woman who was recently started on adalimumab for treatment of her psoriatic arthritis. Results: We discuss the previously published cases in the literature linking alopecia areata to TNF-α inhibitor administration. Our case is the first report of a new-onset alopecia areata following adalimumab. Conclusions: Even though TNF-α is implicated in causing alopecia areata, TNF-α inhibitors have paradoxically been associated with new cases of alopecia areata. It is possible that TNF-α may not be involved in the pathogenesis of alopecia areata, as in vitro studies have suggested.

APA, Harvard, Vancouver, ISO, and other styles

6

Sousa, Brunna Michelly da Silva, Thaís Jales Natal, Tamyres Borges Pereira, Mariana Vieira Martins Sampaio Drummond, and Roberpaulo Anacleto Neves. "Análise comparativa entre os tratamentos para alopecia: uma revisão sistemática." Research, Society and Development 10, no. 15 (November 21, 2021): e134101522770. http://dx.doi.org/10.33448/rsd-v10i15.22770.

Full text

Abstract:

Introdução: A alopecia é a ausência temporária ou congênita de pelos ou cabelos, podendo ser classificada em cicatricial e não cicatricial. Esse estudo focou na análise comparativa dos tratamentos da alopecia areata e androgenética, as quais são alopecias não cicatriciais. A alopecia androgenética é a forma mais comum de perda de cabelo na espécie humana e a alopecia areata possui acometimento de cerca de 2% no âmbito mundial. Objetivo: O estudo visou conhecer, correlacionar e comparar as diferentes formas de tratamento para a alopecia areata e androgenética nos estudos mais recentes. Método: Trata-se de uma revisão sistemática de artigos científicos publicados na base de dados PUBMED entre 01/01/2018 e 31/12/2018. Foram usados os descritores “alopecia areata and treatment” e “alopecia androgenetic and treatment”. Primeiro, os artigos foram analisados pelo título e resumo/abstract por dois revisores (BMSS e TJ), e em caso de desacordos, um terceiro revisor foi consultado (RAN). A seguir, houve uma leitura completa dos textos, e em caso de desacordos, um último revisor foi consultado (RAN). Resultados: A busca por “alopecia areata and treatment” resultou em 26 registros, dos quais 14 foram excluídos. Após a leitura dos artigos na íntegra, dentre os 12 artigos, apenas sete foram utilizados. A busca por “alopecia androgenetic and treatment” resultou em 84 registros, dos quais 61 artigos não atenderam aos critérios de inclusão. Após lidos os 24 artigos, apenas nove foram selecionados. Logo, após a fase de seleção, 16 artigos permaneceram elegíveis. Conclusão: Há uma vasta gama de tratamentos para a alopecia, mostrando que o tratamento deve ser individualizado para cada paciente. Deve-se lembrar sempre de associar a terapia farmacológica ao acompanhamento psicológico, uma vez que o cabelo é também é um instrumento de comunicação.

APA, Harvard, Vancouver, ISO, and other styles

7

Papadopoulos, Anthony J., Robert A. Schwartz, and Camilakrysicka Janniger. "Alopecia Areata." American Journal of Clinical Dermatology 1, no. 2 (March 2000): 101–5. http://dx.doi.org/10.2165/00128071-200001020-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Lun E. Hon, Kam, and Alexander K.C. Leung. "Alopecia Areata." Recent Patents on Inflammation & Allergy Drug Discovery 5, no. 2 (May 1, 2011): 98–107. http://dx.doi.org/10.2174/187221311795399291.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Otlewska, Anna, Agnieszka Otlewska, and Grzegorz Szpotowicz. "Alopecia areata." Pediatria i Medycyna Rodzinna 15, no. 4 (December 31, 2019): 358–61. http://dx.doi.org/10.15557/pimr.2019.0060.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Bujan, Maria. "Alopecia areata." Archivos Argentinos de Pediatria 111, no. 5 (October 1, 2013): 455–56. http://dx.doi.org/10.5546/aap.2013.455.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Rietschel, Robert L. "Alopecia Areata." Immunology and Allergy Clinics of North America 9, no. 3 (December 1989): 543–47. http://dx.doi.org/10.1016/s0889-8561(22)00234-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Zheng, Caiwei, and Antonella Tosti. "Alopecia Areata." Dermatologic Clinics 39, no. 3 (July 2021): 407–15. http://dx.doi.org/10.1016/j.det.2021.03.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Rivas López, Pedro Javier. "Alopecia areata." Revista Medica Sinergia 5, no. 10 (October 1, 2020): e587. http://dx.doi.org/10.31434/rms.v5i10.587.

Full text

Abstract:

La alopecia areata es una enfermedad de origen multifactorial en la cual intervienen la presencia de factores genéticos, ambientales y autoinmunes locales del folículo piloso que terminan causando la pérdida de cabello. Las presentaciones clínicas pueden ser diversas desde el sisaifo hasta la alopecia universalis o alopecia totalis y aunque se trata de una condición benigna, se ha encontrado una importante asociación con otras enfermedades autoinmunes de carácter no tan benigno. Aunque se desconocen todas las vías fisiopatológicas, se ha documentado evidencia clara de una disregulación de las vías de señalización mediadas por las Janus kinasas entre otras. Actualmente existen múltiples tratamientos tópicos y orales para la Alopecia Areata con resultados variables, los inhibidores de Janus Kinasa son una nueva opción terapéutica en investigación.

APA, Harvard, Vancouver, ISO, and other styles

14

Caro, Sarah R. "Alopecia Areata." Journal of the Dermatology Nurses' Association 14, no. 5 (September 2022): 214–19. http://dx.doi.org/10.1097/jdn.0000000000000703.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Höring, C. M., and U. Gieler. "Alopecia Areata." Dermatology and Psychosomatics / Dermatologie und Psychosomatik 3, no. 4 (2002): 196–97. http://dx.doi.org/10.1159/000069259.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Gilhar, Amos, Amos Etzioni, and Ralf Paus. "Alopecia Areata." New England Journal of Medicine 366, no. 16 (April 19, 2012): 1515–25. http://dx.doi.org/10.1056/nejmra1103442.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Oğuz, Oya. "Alopecia areata." TURKDERM 48, S1 (March 15, 2014): 40–44. http://dx.doi.org/10.4274/turkderm.48.s9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Nelson, Dan A., and Richard L. Spielvogel. "Alopecia Areata." International Journal of Dermatology 24, no. 1 (January 1985): 26–34. http://dx.doi.org/10.1111/j.1365-4362.1985.tb05351.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Shapiro, Jerry. "Alopecia Areata." Dermatologic Clinics 11, no. 1 (January 1993): 35–46. http://dx.doi.org/10.1016/s0733-8635(18)30280-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Assouly, P. "Alopecia areata." EMC - Dermatología 40, no. 2 (January 2006): 1–15. http://dx.doi.org/10.1016/s1761-2896(06)46451-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Assouly, P., and O. Dereure. "Alopecia areata." EMC - Dermatología 54, no. 1 (March 2020): 1–14. http://dx.doi.org/10.1016/s1761-2896(20)43361-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Perret, C. M., P. M. Steijlen, and R. Happle. "Alopecia Areata." International Journal of Dermatology 29, no. 2 (March 1990): 83–88. http://dx.doi.org/10.1111/j.1365-4362.1990.tb04074.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

McDonagh, Andrew J. G., and Andrew G. Messenger. "Alopecia areata." Clinics in Dermatology 19, no. 2 (March 2001): 141–47. http://dx.doi.org/10.1016/s0738-081x(00)00134-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Mitchell, Andrew J., and Mark R. Balle. "Alopecia Areata." Dermatologic Clinics 5, no. 3 (July 1987): 553–64. http://dx.doi.org/10.1016/s0733-8635(18)30736-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

García Dorado, Jesús, and Pablo de Unamuno Pérez. "Alopecia areata." FMC - Formación Médica Continuada en Atención Primaria 13, no. 5 (May 2006): 276. http://dx.doi.org/10.1016/s1134-2072(06)71325-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Mas Rosique, Sonia, and Mario Muñoz Organero. "Alopecia areata." FMC - Formación Médica Continuada en Atención Primaria 14, no. 10 (December 2007): 635–36. http://dx.doi.org/10.1016/s1134-2072(07)71950-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Freyschmidt-Paul, P., R. Happle, and R. Hoffmann. "Alopecia areata." Der Hautarzt 54, no. 8 (August 1, 2003): 713–22. http://dx.doi.org/10.1007/s00105-003-0560-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Strazzulla, Lauren C., Eddy Hsi Chun Wang, Lorena Avila, Kristen Lo Sicco, Nooshin Brinster, Angela M. Christiano, and Jerry Shapiro. "Alopecia areata." Journal of the American Academy of Dermatology 78, no. 1 (January 2018): 1–12. http://dx.doi.org/10.1016/j.jaad.2017.04.1141.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Strazzulla, Lauren C., Eddy Hsi Chun Wang, Lorena Avila, Kristen Lo Sicco, Nooshin Brinster, Angela M. Christiano, and Jerry Shapiro. "Alopecia areata." Journal of the American Academy of Dermatology 78, no. 1 (January 2018): 15–24. http://dx.doi.org/10.1016/j.jaad.2017.04.1142.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Rodrigo Sánchez, M. C., M. L. Alonso Pacheco, and L. B. Zambrano Centeno. "Alopecia areata." SEMERGEN - Medicina de Familia 28, no. 4 (January 2002): 212–15. http://dx.doi.org/10.1016/s1138-3593(02)74057-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Wasserman, Dan, Daniela Araucaria Guzman-Sanchez, Kimberly Scott, and Amy McMichael. "Alopecia areata." International Journal of Dermatology 46, no. 2 (February 1, 2007): 121–31. http://dx.doi.org/10.1111/j.1365-4632.2007.03193.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

. "Alopecia areata." Medisch-Farmaceutische Mededelingen 40, no. 7 (July 2002): 223. http://dx.doi.org/10.1007/bf03058001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

von Felbert, V., and H. F. Merk. "Alopecia areata." Der Hautarzt 64, no. 11 (November 2013): 806–9. http://dx.doi.org/10.1007/s00105-013-2576-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Friedli and Harms. "Alopecia areata." Therapeutische Umschau 59, no. 5 (May 1, 2002): 233–37. http://dx.doi.org/10.1024/0040-5930.59.5.233.

Full text

Abstract:

Die Alopecia areata ist eine häufige Krankheit. Die genaue Ursache ist weiterhin nicht klar, auch wenn Hinweise für eine T-zellvermittelte Autoimmunkrankheit bestehen. Genetische, immunologische und psychologische Faktoren spielen eine Rolle. Klinisch handelt es sich meistens um einzelne Zonen nicht vernarbenden Haarausfalls, welche unter einfachen Lokaltherapien in einigen Monaten abheilen. 10 bis 15% der Patienten können eine schwerere Form der Krankheit mit totalem Haar- und/oder Körperhaarverlust erleiden. Der Verlauf ist unvorhersehbar und es bestehen nur wenige prognostische Kriterien. Während orale Kortikosteroide nicht mehr indiziert sind, ist die Korticosteroid-Pulsbehandlung für gewisse multifokale Formen der Alopecia areata effizient. Die PUVA-Therapie und auch die topische Sensibilisierung mit Diphenylcyclopropenon sind zeitintensiver und brauchen Erfahrung, können aber auch in chronischen Fällen wirksam sein. Sehr viele neue Errungenschaften dieser Erkrankung gibt es trotz intensiver Forschung nicht. Eine langfristige Betreuung der Patienen, unter anderem durch Selbsthilfegruppen, ist entsprechend dem oft chronischen Verlauf wichtig.

APA, Harvard, Vancouver, ISO, and other styles

35

Hou, P., and Y. Zhao. "Alopecia areata." American Journal of Dermatopathology 12, no. 3 (June 1990): 315. http://dx.doi.org/10.1097/00000372-199006000-00045.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Fanti, P. A., A. Tosti, F. Bardazzi, L. Guerra, R. Morelli, and N. Cameli. "Alopecia Areata." American Journal of Dermatopathology 16, no. 2 (April 1994): 167–70. http://dx.doi.org/10.1097/00000372-199404000-00011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Zauli, D. "Alopecia areata." Archives of Dermatology 121, no. 2 (February 1, 1985): 169b—169. http://dx.doi.org/10.1001/archderm.121.2.169b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Zauli, D. "Alopecia areata." Archives of Dermatology 122, no. 9 (September 1, 1986): 975–76. http://dx.doi.org/10.1001/archderm.122.9.975.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Kalish, Richard S. "Alopecia Areata." Archives of Dermatology 128, no. 8 (August 1, 1992): 1072. http://dx.doi.org/10.1001/archderm.1992.01680180066007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Fiedler, Virginia C. "Alopecia Areata." Archives of Dermatology 128, no. 11 (November 1, 1992): 1519. http://dx.doi.org/10.1001/archderm.1992.01680210097016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Zauli, Daniela. "Alopecia Areata." Archives of Dermatology 121, no. 2 (February 1, 1985): 169. http://dx.doi.org/10.1001/archderm.1985.01660020027005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Zauli, Daniela. "Alopecia Areata." Archives of Dermatology 122, no. 9 (September 1, 1986): 975. http://dx.doi.org/10.1001/archderm.1986.01660210023009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Lipner, Shari R., and Richard K. Scher. "Alopecia areata." Journal of the American Academy of Dermatology 79, no. 1 (July 2018): e9-e10. http://dx.doi.org/10.1016/j.jaad.2018.01.051.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Hoffmann, R., and R. Happle. "Alopecia areata." Der Hautarzt 50, no. 3 (March 17, 1999): 222–39. http://dx.doi.org/10.1007/s001050050895.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Hoffmann, R., and R. Happle. "Alopecia areata." Der Hautarzt 50, no. 4 (April 14, 1999): 310–15. http://dx.doi.org/10.1007/s001050050912.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

McElwee, K. J., and R. Hoffmann. "Tiermodelle der Alopecia areata . Alopecia areata - animal models." HG Zeitschrift fur Hautkrankheiten 77, no. 7-8 (August 2002): 374–80. http://dx.doi.org/10.1046/j.1439-0353.2002.02555.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Almashagbeh, Shefaa, Ahmad Mohammad Alhadidi, Waseem Alsaleem, Moh’d Alamin Daise, Ahmad Warawreh, Omar Obeidat, and Jowan Al-Nusair. "Assessment of Serum Ferritin Levels in Patients with Alopecia Areata in Jordan." SAS Journal of Medicine 8, no. 11 (November 29, 2022): 839–42. http://dx.doi.org/10.36347/sasjm.2022.v08i11.013.

Full text

Abstract:

Background: Multiple studies have been conducted to look for a relationship between iron body storage and the development of conditions associated with hair loss such as alopecia areata (AA). However, their findings have not been consistent. Therefore, the main objective of this study is to evaluate serum ferritin levels amongst patients with alopecia areata in Jordan. Methods: This study looked into ferritin levels among alopecia areata patients and compared them with the controls. Diagnosis of alopecia areata was done clinically and the selected patients were investigated for serum ferritin and hemoglobin. Results: Amongst our study sample, which included 183 patients; 97 patients were in the alopecia areata group and 86 were in the control group. Out of the Alopecia Areata group, 62(63.9%) were males and 35(36.1%) were females with a mean age of 29.9 years. As for the control group, 45(52.3%) were males and 41(47.7%) were females with a mean age of 32.05 years. We drew the inference that the serum ferritin was significantly higher in the alopecia areata group. Conclusion: We concluded that the numerical value for serum ferritin was significantly higher in the alopecia areata group but was still within normal range.

APA, Harvard, Vancouver, ISO, and other styles

48

Tassone, Francesco, Simone Cappilli, Flaminia Antonelli, Ruggiero Zingarelli, Andrea Chiricozzi, and Ketty Peris. "Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study." Vaccines 10, no. 9 (September 5, 2022): 1467. http://dx.doi.org/10.3390/vaccines10091467.

Full text

Abstract:

Limited data concerning the development of autoimmune skin diseases after COVID-19 vaccination are currently available. Recently, a few reports described the development, worsening or recurrence of alopecia areata after the administration of COVID-19 vaccines. High variability in terms of disease onset following vaccination as well as the heterogeneous topical and/or systemic treatment approaches have been described. Methods: All patient-related data and images were obtained as part of clinical routine. Diagnosis of alopecia areata was established according to clinical and trichoscopic findings, along with the exclusion of common differential diagnoses. Results. Twenty-four patients, 20 females (83.3%) and four males (16.7%), with a mean age of 39.1 years (age range: 14–66 years), were examined for the occurrence of alopecia areata within 16 weeks after COVID-19 vaccination. Out of 24, 14 patients (58.3%) experienced a patchy alopecia areata, while an extensive disease occurred in 10/24 patients (41.7%): six patients with whole scalp involvement (alopecia areata totalis) and four patients with the whole body affected (alopecia areata universalis). Twelve patients reported a history of autoimmune disease (50%). Treatment with topical corticosteroid was performed in almost all patients with patchy alopecia areata, whilst it was associated with systemic drugs (corticosteroids, minoxidil, cyclosporin) in the case of generalized alopecia areata and alopecia areata universalis. Mean baseline values of Severity of Alopecia Tool (SALT) score decreased from 43.4 to 36.6 after 12 weeks of treatment, with evidence of hair regrowth in 16/21 patients. Conclusion. This study described the occurrence of alopecia areata after COVID-19 vaccination and its management that implicates the use of both topical and systemic therapies.

APA, Harvard, Vancouver, ISO, and other styles

49

Saravanan, Gowtham, and Karthikeyan Kaliyaperumal. "Does zinc have a role in alopecia areata? A clinic-biochemical study." Global Journal of Health Sciences and Research 1 (February 20, 2023): 18–21. http://dx.doi.org/10.25259/gjhsr_8_2022.

Full text

Abstract:

Objectives: (1) The objectives of the study are as follows: To study serum zinc levels in patients with alopecia areata. (2) To study the correlation between serum zinc levels and severity of alopecia areata. Material and Methods: A hospital-based and cross-sectional study was conducted in our out-patient Department of Dermatology and STD. All new cases of alopecia areata were included in this study. The patients with clinical features of Systemic Lupus Erythematosus and other autoimmune disorders were excluded from the study. After obtaining a detailed history and examination and confirmation by hair pull test and dermoscopy, the severity of alopecia was graded by Severity of Alopecia Tool score and gauging score. Serum zinc levels of the patients were then measured by calorimetric method. Results: A total of 88 cases who met the criteria were chosen. Majority of patients were between 20 and 40 years of age with a male preponderance. Patchy pattern of alopecia was the most common pattern noted with scalp being the most commonly involved site. Serum zinc was deficient in around 52.2% of cases. Most of the patients had mild alopecia areata. No significant association was noted between serum zinc levels and alopecia areata. Furthermore, there was no correlation between the severity of alopecia areata and serum zinc levels. Conclusion: In our study, no association was noted between serum zinc levels and alopecia areata. Furthermore, the severity of alopecia areata did not correlate with serum zinc levels.

APA, Harvard, Vancouver, ISO, and other styles

50

Kouassi, Yao Isidore, and Koffi Kouamé Pacôme GBANDAMA. "Alopecia areata in Black African patients: epidemiological, clinical, and therapeutic aspects." Our Dermatology Online 12, no. 1 (January 2, 2021): 24–26. http://dx.doi.org/10.7241/ourd.20211.5.

Full text

Abstract:

Background: The aim was to describe the epidemiological, clinical, and therapeutic aspects of alopecia areata in Black African patients. Material and Methods: This was a retrospective descriptive study conducted at the Dermatology and Venerology Department of the University Hospital Center of Treichville over a 5-year. Results: The prevalence of alopecia areata was 0.2%. The mean age was 24.6 years and the male-to-female ratio was 1.47. Stress preceding the symptomatology was found in 3 cases. As for the clinical distribution, there were 25 cases of plaque-type alopecia areata, 10 cases of total descending alopecia areata, and 7 cases of universal alopecia areata. There was no nail damage and no associated pathologies. Local treatment only was administered in 31 cases, local and systemic treatment in 8 cases, and systemic treatment only in 3 cases. Conclusions: Alopecia areata predominates in young male populations and pathologies associated with alopecia are very rare.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!